Aplagon
PrivateLast Round
Early Funding
Jun 16, 2026
Total Funding Raised
$15.02M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Aplagon is a clinical-stage biopharmaceutical company that develops first-in-class therapeutics for thromboinflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aplagon Comparables
Compare Aplagon with similar companies based on industry and business-model similarity.
Aplagon Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 16, 2026 | ||||
| Series A | Feb 3, 2025 | ||||
| Grant | Nov 16, 2022 | ||||
| VC Round | May 28, 2021 | ||||
| Seed | Dec 7, 2018 |
Aplagon Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council | Early Funding, Series A |
| Innovestor | Early Funding, Series A, Seed |
| Helsinki University Funds | Seed |
| Invesdor | VC Round |
| Fåhraeus Startup and Growth | Early Funding, Series A |
| Finnvera | Seed |
| Jenny and Antti Wihuri Foundation | Early Funding, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
$6M raised with eic-ec-europa and Fåhraeus Startup and Growth leading.
- Jan 23, 2026
Monthly visitors grew 98% MoM.
Aplagon Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aplagon's valuation, stock price, and market status.